Japan device funding
This article was originally published in The Gray Sheet
Executive Summary
Government adopts resolution of fairness guaranteeing new Comprehensive Organization for Medicines & Medical Equipment will ensure public accountability, according to Pacific Bridge President Ames Gross. Stakeholders were concerned that the new body, expected to be funded mainly by pharmaceutical firms, would cater to the needs of drug companies. The new group will launch in April 2004 (1"The Gray Sheet" March 10, 2003, p. 37)...
You may also be interested in...
Japan Device Pricing To Benefit From Hospital Efficiency Incentives
The Ministry of Health, Labor & Welfare in Japan will offer hospitals a 15% bonus payment for reducing the time patients remain in the inpatient setting, provided the centers fall within the top length-of-stay quartile
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.